Anti-cancer compounds

US10562886B2 · kind B2 · utility

Assignee

• The Regents of the University of California · US

Inventors

• Csaba J. Peto · Alameda, US
• David M. Jablons · San Francisco, US
• Hassan Lemjabbar-Alaoui · San Francisco, US

Key dates

• Filing date: May 23, 2016
• Grant date: Feb 18, 2020
• Expiry date: May 23, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D403/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention provides, among other things, compounds useful for treating diseases such as cancer, pharmaceutical formulations containing such compounds, as well as combinations of these compounds with at least one additional therapeutic agent.